![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
ITPA Deficiency is Associated with Lower Rates of Anemia and EPO use in Patients Treated with Boceprevir (BOC) plus Peginterferon/Ribavirin (PR)
|
|
|
Reported by jules Levin AASLD Nov 5-8 2011 SF
Mark S. Sulkowski MD1; K. Rajender Reddy MD2; Lisa D. Pedicone PhD3; Junwu Shen PhD3; Margaret Burroughs MD3; Clifford A. Brass MD, PhD3; Janice K. Albrecht PhD3; Michael P. Manns MD4
1Johns Hopkins University School of Medicine, Baltimore, MD, USA; 2University of Pennsylvania, Philadelphia, PA, USA;
3Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA; 4Medical School of Hannover, Hannover, Germany
![AASLD1.gif](../images/111911/111911-2/AASLD1.gif)
![AASLD2.gif](../images/111911/111911-2/AASLD2.gif)
![AASLD3.gif](../images/111911/111911-2/AASLD3.gif)
![AASLD4.gif](../images/111911/111911-2/AASLD4.gif)
![AASLD5.gif](../images/111911/111911-2/AASLD5.gif)
![AASLD6.gif](../images/111911/111911-2/AASLD6.gif)
![AASLD7.gif](../images/111911/111911-2/AASLD7.gif)
![AASLD8.gif](../images/111911/111911-2/AASLD8.gif)
![AASLD9.gif](../images/111911/111911-2/AASLD9.gif)
![AASLD10.gif](../images/111911/111911-2/AASLD10.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|